Christopher W. Fulton

Array ( [id] => 1290273 [patent_doc_number] => 06632919 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-14 [patent_title] => 'Peptide nucleic acid monomers and oligomers' [patent_app_type] => B1 [patent_app_number] => 09/083235 [patent_app_country] => US [patent_app_date] => 1998-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28152 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 208 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/632/06632919.pdf [firstpage_image] =>[orig_patent_app_number] => 09083235 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4386678 [patent_doc_number] => 06262256 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-17 [patent_title] => 'Article for tuesyl-activated dextran for solid-phase coupling' [patent_app_type] => 1 [patent_app_number] => 9/073646 [patent_app_country] => US [patent_app_date] => 1998-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 13 [patent_no_of_words] => 9280 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/262/06262256.pdf [firstpage_image] =>[orig_patent_app_number] => 073646 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1387968 [patent_doc_number] => 06548480 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-15 [patent_title] => 'Phosphonic acid derivatives with metallopeptidase inhibitory activity' [patent_app_type] => B1 [patent_app_number] => 09/068107 [patent_app_country] => US [patent_app_date] => 1998-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5953 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 373 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/548/06548480.pdf [firstpage_image] =>[orig_patent_app_number] => 09068107 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4303903 [patent_doc_number] => 06251868 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-26 [patent_title] => 'Method for treating a human immunodeficiency virus infection' [patent_app_type] => 1 [patent_app_number] => 9/069809 [patent_app_country] => US [patent_app_date] => 1998-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 11 [patent_no_of_words] => 4926 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/251/06251868.pdf [firstpage_image] =>[orig_patent_app_number] => 069809 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1554200 [patent_doc_number] => 06348572 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-19 [patent_title] => 'Ligands for phosphatase binding assay' [patent_app_type] => B1 [patent_app_number] => 09/069138 [patent_app_country] => US [patent_app_date] => 1998-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 18189 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/348/06348572.pdf [firstpage_image] =>[orig_patent_app_number] => 09069138 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4034253 [patent_doc_number] => 05942500 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-24 [patent_title] => 'Dietary composition to reduce dietary fats' [patent_app_type] => 1 [patent_app_number] => 9/067532 [patent_app_country] => US [patent_app_date] => 1998-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3568 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/942/05942500.pdf [firstpage_image] =>[orig_patent_app_number] => 067532 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4240437 [patent_doc_number] => 06143931 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-07 [patent_title] => 'Synthesis and use of .alpha.-ketoamide derivatives and arrays' [patent_app_type] => 1 [patent_app_number] => 9/061752 [patent_app_country] => US [patent_app_date] => 1998-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 7289 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/143/06143931.pdf [firstpage_image] =>[orig_patent_app_number] => 061752 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1553760 [patent_doc_number] => 06348448 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-19 [patent_title] => 'Peptidyl-2-amino-1-hydroxyalkanesulfonic acid cysteine protease inhibitors' [patent_app_type] => B1 [patent_app_number] => 09/060491 [patent_app_country] => US [patent_app_date] => 1998-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5302 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 467 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/348/06348448.pdf [firstpage_image] =>[orig_patent_app_number] => 09060491 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3945686 [patent_doc_number] => 05977076 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-02 [patent_title] => 'Method and material for inhibiting complement' [patent_app_type] => 1 [patent_app_number] => 9/060393 [patent_app_country] => US [patent_app_date] => 1998-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 16 [patent_no_of_words] => 7362 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/977/05977076.pdf [firstpage_image] =>[orig_patent_app_number] => 060393 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4000196 [patent_doc_number] => 05986136 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-16 [patent_title] => 'Photolabeling reagent' [patent_app_type] => 1 [patent_app_number] => 9/057799 [patent_app_country] => US [patent_app_date] => 1998-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 11776 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/986/05986136.pdf [firstpage_image] =>[orig_patent_app_number] => 057799 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4134163 [patent_doc_number] => 06034216 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-07 [patent_title] => 'Low molecular weight peptidomimetic growth hormone secretagogues' [patent_app_type] => 1 [patent_app_number] => 9/057074 [patent_app_country] => US [patent_app_date] => 1998-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 30 [patent_no_of_words] => 46074 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 453 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/034/06034216.pdf [firstpage_image] =>[orig_patent_app_number] => 057074 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3985971 [patent_doc_number] => 05959077 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-28 [patent_title] => 'Hepatotropic conjugates of antiviral drugs carriers thereof and pharmaceutical compositions containing them' [patent_app_type] => 1 [patent_app_number] => 9/053279 [patent_app_country] => US [patent_app_date] => 1998-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 17 [patent_no_of_words] => 7581 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/959/05959077.pdf [firstpage_image] =>[orig_patent_app_number] => 053279 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4216065 [patent_doc_number] => 06110890 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-29 [patent_title] => 'Treatment of Dutch elm disease' [patent_app_type] => 1 [patent_app_number] => 9/048052 [patent_app_country] => US [patent_app_date] => 1998-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 4 [patent_no_of_words] => 5972 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/110/06110890.pdf [firstpage_image] =>[orig_patent_app_number] => 048052 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4108936 [patent_doc_number] => 06057297 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-02 [patent_title] => 'Inhibitor compounds of zinc-dependent metalloproteinases associated with pathological conditions, and therapeutic use thereof' [patent_app_type] => 1 [patent_app_number] => 9/040446 [patent_app_country] => US [patent_app_date] => 1998-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11921 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/057/06057297.pdf [firstpage_image] =>[orig_patent_app_number] => 040446 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6908303 [patent_doc_number] => 20010011070 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-08-02 [patent_title] => 'USE OF THREONINE FOR THE TREATMENT OF PHENYLKETONURIA' [patent_app_type] => new [patent_app_number] => 09/029064 [patent_app_country] => US [patent_app_date] => 1998-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2052 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0011/20010011070.pdf [firstpage_image] =>[orig_patent_app_number] => 09029064 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 774169 [patent_doc_number] => 07001983 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-02-21 [patent_title] => 'Antipathogenic synthetic peptides and compositions comprising them' [patent_app_type] => utility [patent_app_number] => 09/367714 [patent_app_country] => US [patent_app_date] => 1998-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 20226 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 500 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/001/07001983.pdf [firstpage_image] =>[orig_patent_app_number] => 09367714 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1495387 [patent_doc_number] => 06403561 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-11 [patent_title] => 'Tripeptidylpeptidase inhibitors' [patent_app_type] => B1 [patent_app_number] => 08/930055 [patent_app_country] => US [patent_app_date] => 1998-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41163 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 212 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/403/06403561.pdf [firstpage_image] =>[orig_patent_app_number] => 08930055 [rel_patent_id] =>[rel_patent_doc_number] =>)